| scholarly article | Q13442814 |
| P2093 | author name string | Sukhminder Jit Singh Bajwa | |
| Sukhwinder Kaur Bajwa | |||
| Vishal Sehgal | |||
| P2860 | cites work | Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults | Q22250906 |
| Early goal-directed therapy in the treatment of severe sepsis and septic shock | Q27860596 | ||
| Pharmacology of sedative-analgesic agents: dexmedetomidine, remifentanil, ketamine, volatile anesthetics, and the role of peripheral mu antagonists | Q28250766 | ||
| Risks of general anaesthesia in people with obstructive sleep apnoea | Q28289131 | ||
| Prevalence of overweight and obesity in the United States, 1999-2004 | Q28305811 | ||
| Intensive insulin therapy in critically ill patients | Q29618795 | ||
| Pulmonary complications of obesity | Q30307260 | ||
| Critical care of patients with obesity. | Q30434360 | ||
| Effect of body position on spontaneous respiratory rate and tidal volume in patients with obesity, abdominal distension and ascites | Q30466529 | ||
| Dosing and monitoring of low-molecular-weight heparins in special populations | Q32049893 | ||
| Obesity prevalence from a European perspective: a systematic review | Q33340814 | ||
| Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature | Q33388371 | ||
| Pulmonary physiologic changes of morbid obesity | Q33770783 | ||
| ABC of hypertension. Blood pressure measurement. Part I-sphygmomanometry: factors common to all techniques | Q33805120 | ||
| Sedation in the intensive care unit | Q33884496 | ||
| Effects of obesity on pharmacokinetics implications for drug therapy | Q34053786 | ||
| Treatment of ARDS. | Q34395656 | ||
| A prospective study of risk factors for pulmonary embolism in women | Q34417008 | ||
| Use of propofol and other nonbenzodiazepine sedatives in the intensive care unit | Q34474032 | ||
| Pressure ulcers in the chronically critically ill patient | Q34761377 | ||
| Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients. | Q54154576 | ||
| Effect of exercise on left ventricular systolic function and reserve in morbid obesity | Q69304191 | ||
| Preoperative pulmonary function testing to predict postoperative morbidity and mortality | Q69989752 | ||
| Obesity and left ventricular diastolic dysfunction | Q71258197 | ||
| Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects | Q72570100 | ||
| Ethnic-specific cutpoints for obesity vs country-specific guidelines for action | Q73107453 | ||
| Current practices in the prophylaxis of venous thromboembolism in bariatric surgery | Q73545045 | ||
| The obesity hypoventilation syndrome can be treated with noninvasive mechanical ventilation | Q73735740 | ||
| Safety of bedside percutaneous dilatational tracheostomy in obese patients in the ICU | Q73783559 | ||
| Chest mechanics in morbidly obese non-hypoventilated patients | Q73792642 | ||
| A comparison of mini-bronchoalveolar lavage and blind-protected specimen brush sampling in ventilated patients with suspected pneumonia | Q74649801 | ||
| Prevention of venous thromboembolism | Q77579049 | ||
| Sedation in the intensive care unit | Q78391628 | ||
| Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). | Q34978093 | ||
| Palonosetron: A novel approach to control postoperative nausea and vomiting in day care surgery | Q35006180 | ||
| Medical and surgical options in the treatment of severe obesity | Q35044812 | ||
| Cardiovascular management of septic shock | Q35081658 | ||
| Skin and wound care challenges in the hospitalized morbidly obese patient | Q35092482 | ||
| Critical care of the obese and bariatric surgical patient | Q35104524 | ||
| Morbid obesity: the disease and comorbidities | Q35126532 | ||
| Principles and practices in the management of obesity | Q35187875 | ||
| Adaptation to the Intensive Care Environment (ATICE): Development and validation of a new sedation assessment instrument | Q35539695 | ||
| Dosing of medications in morbidly obese patients in the intensive care unit setting | Q35587926 | ||
| Clinical approach to the critically ill, morbidly obese patient | Q35675079 | ||
| Surgery for severe obesity | Q35688274 | ||
| Assessment and management of the obese patient | Q35738412 | ||
| Outcome of morbid obesity in the intensive care unit | Q36124473 | ||
| Nutritional care of the obese intensive care unit patient | Q36193314 | ||
| Pharmacokinetic and pharmacodynamic characteristics of medications used for moderate sedation | Q36574931 | ||
| Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares | Q37217057 | ||
| Low-molecular-weight heparins in renal impairment and obesity: available evidence and clinical practice recommendations across medical and surgical settings | Q37490581 | ||
| Physiology of obesity and effects on lung function | Q37624329 | ||
| Effect of obesity on the pharmacokinetics of drugs in humans | Q37672600 | ||
| Immunologic Changes in Obesity | Q37802494 | ||
| Gas exchange during anaesthesia | Q37920725 | ||
| Dexmedetomidine in anaesthesia practice: A wonder drug? | Q38670767 | ||
| The obese patient in the ICU. | Q41719726 | ||
| Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular- weight heparin for the treatment of venous thromboembolism | Q43642138 | ||
| Ultrasound-guided central venous cannulation in bariatric patients | Q44166858 | ||
| Daily hemodialysis and the outcome of acute renal failure | Q44215628 | ||
| Use of critical care resources after laparoscopic gastric bypass: effect on respiratory complications | Q44739965 | ||
| Morbid obesity and tracheal intubation | Q46075781 | ||
| Intensive versus conventional glucose control in critically ill patients | Q46076336 | ||
| Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity | Q46762889 | ||
| Improved results using ultrasound guidance for central venous access. | Q47289728 | ||
| Predicting energy needs in ventilator-dependent critically ill patients: effect of adjusting weight for edema or adiposity | Q47300437 | ||
| Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery | Q47375546 | ||
| Preoperative factors predictive of complicated postoperative management after Roux-en-Y gastric bypass for morbid obesity | Q47576774 | ||
| Morbid obesity in the medical ICU. | Q48676735 | ||
| Leptin prevents respiratory depression in obesity | Q48764953 | ||
| Sleep apnea and sleep disruption in obese patients | Q48835547 | ||
| Ultrasound guidance versus the landmark technique for the placement of central venous catheters in the emergency department | Q50109811 | ||
| Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. | Q51401261 | ||
| Critical respiratory events in the postanesthesia care unit. Patient, surgical, and anesthetic factors. | Q51627667 | ||
| P433 | issue | 5 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 740-748 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Indian Journal of Endocrinology and Metabolism | Q15816442 |
| P1476 | title | Clinical and critical care concerns in severely ill obese patient | |
| P478 | volume | 16 |
| Q34236822 | Anaesthetic challenges and management during pregnancy: Strategies revisited |
| Q48118372 | Assessing Propylene Glycol Toxicity in Alcohol Withdrawal Patients Receiving Intravenous Benzodiazepines: A One-Compartment Pharmacokinetic Model |
| Q27022818 | Clinical conundrums in management of hypothyroidism in critically ill geriatric patients |
| Q48238249 | Intensive care nurses' experiences of caring for obese intensive care patients: A hermeneutic study. |
| Q36894693 | Intravenous analgesia with opioids versus femoral nerve block with 0.2% ropivacaine as preemptive analgesic for fracture femur: A randomized comparative study |
| Q26827362 | Management of diabetes in the elderly with canagliflozin: A newer hypoglycemic drug on the horizon |
| Q34196827 | Predictors of acute kidney injury in geriatric patients undergoing total knee replacement surgery |
| Q34236973 | Pregnancy with co-morbidities: Anesthetic aspects during operative intervention |
| Q40148916 | The Effect of Morbid Obesity on Subarachnoid Hemorrhage Prognosis in the United States. |
Search more.